These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 17416766)
1. IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States. Slattery ML; Curtin K; Baumgartner R; Sweeney C; Byers T; Giuliano AR; Baumgartner KB; Wolff RR Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):747-55. PubMed ID: 17416766 [TBL] [Abstract][Full Text] [Related]
2. Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk. Slattery ML; Curtin K; Sweeney C; Wolff RK; Baumgartner RN; Baumgartner KB; Giuliano AR; Byers T Obesity (Silver Spring); 2008 Feb; 16(2):339-47. PubMed ID: 18239642 [TBL] [Abstract][Full Text] [Related]
3. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States. Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998 [TBL] [Abstract][Full Text] [Related]
4. Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women. Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; John EM; Hines LM; Stern MC; Giuliano AR; Torres-Mejia G; Brock GN; Groves FD; Kerber RA; Wolff RK; Slattery ML Breast Cancer Res Treat; 2013 Sep; 141(2):287-97. PubMed ID: 24036662 [TBL] [Abstract][Full Text] [Related]
5. ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States. Slattery ML; Sweeney C; Herrick J; Wolff R; Baumgartner K; Giuliano A; Byers T Breast Cancer Res Treat; 2007 Nov; 105(3):327-35. PubMed ID: 17187234 [TBL] [Abstract][Full Text] [Related]
6. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women. Fejerman L; Stern MC; Ziv E; John EM; Torres-Mejia G; Hines LM; Wolff R; Wang W; Baumgartner KB; Giuliano AR; Slattery ML Carcinogenesis; 2013 Aug; 34(8):1787-93. PubMed ID: 23563089 [TBL] [Abstract][Full Text] [Related]
7. Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study. Connor AE; Baumgartner RN; Baumgartner KB; Kerber RA; Pinkston C; John EM; Torres-Mejia G; Hines L; Giuliano A; Wolff RK; Slattery ML Breast Cancer Res Treat; 2012 Nov; 136(2):593-602. PubMed ID: 23085767 [TBL] [Abstract][Full Text] [Related]
8. IL6 genotypes and colon and rectal cancer. Slattery ML; Wolff RK; Herrick JS; Caan BJ; Potter JD Cancer Causes Control; 2007 Dec; 18(10):1095-105. PubMed ID: 17694420 [TBL] [Abstract][Full Text] [Related]
9. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426 [TBL] [Abstract][Full Text] [Related]
10. Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer. Padala C; Puranam K; Shyamala N; Kupsal K; Kummari R; Galimudi RK; Gundapaneni KK; Tupurani MA; Suryadevera A; Chinta SK; Manavathi B; Hanumanth SR Cytokine; 2022 Dec; 160():156024. PubMed ID: 36182709 [TBL] [Abstract][Full Text] [Related]
11. Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Slattery ML; Baumgartner KB; Byers T; Guiliano A; Sweeney C; Herrick J; Curtin K; Murtaugh M; Wolff R Cancer Causes Control; 2005 Dec; 16(10):1147-57. PubMed ID: 16215864 [TBL] [Abstract][Full Text] [Related]
12. Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study. Slattery ML; John EM; Torres-Mejia G; Herrick JS; Giuliano AR; Baumgartner KB; Hines LM; Wolff RK Int J Cancer; 2013 Jun; 132(12):2928-39. PubMed ID: 23180569 [TBL] [Abstract][Full Text] [Related]
13. Physical activity and breast cancer risk among women in the southwestern United States. Slattery ML; Edwards S; Murtaugh MA; Sweeney C; Herrick J; Byers T; Giuliano AR; Baumgartner KB Ann Epidemiol; 2007 May; 17(5):342-53. PubMed ID: 17462544 [TBL] [Abstract][Full Text] [Related]
14. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411 [TBL] [Abstract][Full Text] [Related]
15. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India. Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964 [TBL] [Abstract][Full Text] [Related]
16. ADRB2 G-G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity. Connor A; Baumgartner RN; Kerber RA; O'Brien E; Rai SN; Wolff RK; Slattery ML; Giuliano AR; Risendal BC; Byers TE; Baumgartner KB Cancer Causes Control; 2012 Oct; 23(10):1653-63. PubMed ID: 22864926 [TBL] [Abstract][Full Text] [Related]
17. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Vozarova B; Fernández-Real JM; Knowler WC; Gallart L; Hanson RL; Gruber JD; Ricart W; Vendrell J; Richart C; Tataranni PA; Wolford JK Hum Genet; 2003 Apr; 112(4):409-13. PubMed ID: 12589429 [TBL] [Abstract][Full Text] [Related]
18. Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study. Slattery ML; Lundgreen A; Hines LM; Torres-Mejia G; Wolff RK; Stern MC; John EM Breast Cancer Res Treat; 2014 Aug; 147(1):145-58. PubMed ID: 25104439 [TBL] [Abstract][Full Text] [Related]
19. Genetic admixture among Hispanics and candidate gene polymorphisms: potential for confounding in a breast cancer study? Sweeney C; Wolff RK; Byers T; Baumgartner KB; Giuliano AR; Herrick JS; Murtaugh MA; Samowitz WS; Slattery ML Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):142-50. PubMed ID: 17220343 [TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]